Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol

Companies will collaborate on manufacturing and research and development for future indications, and will commercialize Gadopiclenol independently under separate brands Gadopiclenol is a next-generation, macrocyclic contrast agent with high-relaxivity, intended to improve lesion detection and vi...